百利科技(603959.SH)股東德清通利參與轉融通證券出借業務
格隆匯6月8日丨百利科技(603959.SH)公佈,公司近日收到股東德清通利企業管理合夥企業(有限合夥)(“德清通利”)參與轉融通證券出借交易的通知,具體事項如下:
德清通利近期參與轉融通證券出借業務,將其持有的公司無限售流通股360萬股(佔公司總股本的0.82%)轉入中國證券金融股份有限公司開立的客户信用擔保證券賬户中,該部分股份所有權未發生轉移。
截至公告日,德清通利共持有公司無限售流通股合計約2727.23萬股,佔公司總股本的6.21%。其中,存放於中國證券金融股份有限公司客户信用擔保證券賬户的公司股份為360萬股,佔其所持有公司股份總數的13.20%,佔公司總股本的0.82%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.